Does Stallergenes Greer provide solutions for food allergies?
Yes, Stallergenes Greer is the first allergen immunotherapy company to offer both respiratory and food allergy treatments.
The Group recently acquired Palforzia® (powder to be consumed with semi-solid foods), which is currently the only available approved treatment for inadvertent exposure to peanut.
Peanut allergy currently affects approximately 2% of the general population of Western nations 1, and the prevalence of peanut allergy doubled among children between 2005 and 20152. The difficulty of avoiding peanut, combined with the severity of allergic reactions, including anaphylaxis, shows the need for an effective treatment.
1. The global burden of illness of peanut allergy: A comprehensive literature review. Jay A. Lieberman, Ruchi S Gupta, Rebecca C. Knibb, Tmirah Haselkorn, Stephen Tilles, Douglas P. Mack, and Guillaume Pouessel. Online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247890/. Consulté le 31 Août, 2023.
2. Du Toit G, et al. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. N Engl J Med 2015; 372: 803-13. Consulté le 31 Août, 2023.
Palforzia®: © 2023, Société des Produits Nestlé S.A. or its affiliates